Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.04 trillion and total revenue of $109.96 billion.
Market Cap
1.04T
Revenue
109.96B
Profits
-42.27B
PE Ratio
n/a
Profit Margin
-38.44%
Dividend Yield
0.05%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 113.96B | -0.58% | 1,224,082 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 78.41B | 0.70% | 507,958 | 14.34B |
| 3 | ARGX | argenx SE | 41.93B | -0.64% | 274,916 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.85B | 0.45% | 1,497,319 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 30.56B | 0.35% | 240,723 | 5.34B |
| 6 | INSM | Insmed Incorporated | 29.99B | -3.36% | 2,816,858 | 606.42M |
| 7 | BNTX | BioNTech SE | 21.82B | -1.81% | 1,085,681 | 3.37B |
| 8 | MRNA | Moderna, Inc. | 20.28B | 0.12% | 4,808,239 | 1.94B |
| 9 | RPRX | Royalty Pharma plc | 19.52B | -0.09% | 2,490,365 | 2.38B |
| 10 | ROIV | Roivant Sciences Ltd. | 19.23B | -3.80% | 4,087,784 | 13.31M |
| 11 | RVMD | Revolution Medicines, Inc. | 18.93B | -1.15% | 1,528,750 | - |
| 12 | INCY | Incyte Corporation | 18.03B | 0.19% | 1,584,071 | 5.14B |
| 13 | GMAB | Genmab A/S | 15.70B | 0.51% | 1,562,047 | 3.72B |
| 14 | BBIO | BridgeBio Pharma, Inc. | 13.29B | -1.54% | 1,518,143 | 502.08M |
| 15 | ASND | Ascendis Pharma A/S | 13.23B | -1.16% | 259,283 | 845.52M |
| 16 | SMMT | Summit Therapeutics Inc. | 12.05B | -0.38% | 2,107,885 | - |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 11.51B | -1.57% | 1,844,377 | 943.71M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 11.39B | 1.48% | 1,476,659 | 4.27B |
| 19 | EXEL | Exelixis, Inc. | 10.80B | 0.39% | 2,540,023 | 2.32B |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 10.40B | -1.26% | 1,696,577 | 3.22B |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.21B | -0.60% | 234,706 | 958.40M |
| 22 | ABVX | ABIVAX Société Anonyme | 8.65B | -4.55% | 2,334,156 | 5.37M |
| 23 | PRAX | Praxis Precision Medicines, Inc. | 8.21B | 0.18% | 489,877 | 7.46M |
| 24 | TECH | Bio-Techne Corporation | 8.20B | 0.83% | 1,839,185 | 1.22B |
| 25 | AXSM | Axsome Therapeutics, Inc. | 8.12B | 1.22% | 1,251,778 | 638.50M |
| 26 | ARWR | Arrowhead Pharmaceuticals, Inc. | 7.88B | -0.71% | 2,003,538 | 1.09B |
| 27 | PCVX | Vaxcyte, Inc. | 7.87B | -2.27% | 1,003,872 | - |
| 28 | IBRX | ImmunityBio, Inc. | 7.62B | -21.12% | 86,939,369 | 113.29M |
| 29 | NUVL | Nuvalent, Inc. | 7.56B | -0.29% | 417,839 | - |
| 30 | CYTK | Cytokinetics, Incorporated | 7.39B | -1.53% | 2,106,314 | 88.04M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.32B | -1.30% | 1,245,035 | 1.40B |
| 32 | KRYS | Krystal Biotech, Inc. | 7.22B | -1.20% | 271,518 | 389.13M |
| 33 | ACLX | Arcellx, Inc. | 6.71B | 0.08% | 1,800,319 | 22.29M |
| 34 | PTGX | Protagonist Therapeutics, Inc. | 6.41B | 1.88% | 940,176 | 46.02M |
| 35 | KYMR | Kymera Therapeutics, Inc. | 6.08B | -3.30% | 596,535 | 39.21M |
| 36 | BLTE | Belite Bio, Inc | 5.93B | -0.10% | 175,801 | - |
| 37 | COGT | Cogent Biosciences, Inc. | 5.67B | -1.27% | 1,897,975 | - |
| 38 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.64B | -2.43% | 894,972 | 189.76M |
| 39 | CAI | Caris Life Sciences, Inc. | 5.44B | -0.10% | 3,790,886 | 812.03M |
| 40 | CGON | CG Oncology, Inc. | 5.39B | -1.72% | 989,588 | 4.04M |
| 41 | PTCT | PTC Therapeutics, Inc. | 5.34B | -2.83% | 1,164,632 | 1.73B |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 5.30B | -1.73% | 969,083 | 521.31M |
| 43 | XENE | Xenon Pharmaceuticals Inc. | 5.09B | -1.91% | 1,141,330 | 7.50M |
| 44 | APGE | Apogee Therapeutics, Inc. | 5.07B | -7.87% | 2,148,581 | - |
| 45 | SRRK | Scholar Rock Holding Corporation | 4.86B | -3.11% | 2,173,141 | - |
| 46 | IMVT | Immunovant, Inc. | 4.85B | -2.21% | 1,381,010 | - |
| 47 | TGTX | TG Therapeutics, Inc. | 4.83B | -0.76% | 1,556,539 | 616.29M |
| 48 | CELC | Celcuity Inc. | 4.72B | -4.44% | 606,195 | - |
| 49 | ERAS | Erasca, Inc. | 4.56B | 2.44% | 4,060,388 | - |
| 50 | FOLD | Amicus Therapeutics, Inc. | 4.52B | -0.07% | 3,405,762 | 634.21M |
| 51 | TERN | Terns Pharmaceuticals, Inc. | 4.50B | 0.79% | 2,544,593 | - |
| 52 | CRSP | CRISPR Therapeutics AG | 4.46B | -0.96% | 1,185,632 | 3.51M |
| 53 | LGND | Ligand Pharmaceuticals Incorporated | 4.02B | 0.65% | 214,682 | 268.09M |
| 54 | CNTA | Centessa Pharmaceuticals plc | 3.75B | 7.52% | 2,268,835 | 15.00M |
| 55 | VKTX | Viking Therapeutics, Inc. | 3.72B | -1.17% | 2,289,989 | - |
| 56 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.60B | -0.98% | 1,217,027 | 7.70M |
| 57 | CORT | Corcept Therapeutics Incorporated | 3.60B | 0.56% | 1,242,425 | 761.41M |
| 58 | ACAD | ACADIA Pharmaceuticals Inc. | 3.57B | -0.14% | 1,989,930 | 1.07B |
| 59 | DNTH | Dianthus Therapeutics, Inc. | 3.49B | -0.97% | 866,383 | 2.04M |
| 60 | NAMS | NewAmsterdam Pharma Company N.V. | 3.46B | 0.17% | 644,886 | 22.50M |
| 61 | GPCR | Structure Therapeutics Inc. | 3.33B | -4.12% | 777,269 | - |
| 62 | DNLI | Denali Therapeutics Inc. | 3.33B | -0.57% | 1,627,456 | - |
| 63 | SYRE | Spyre Therapeutics, Inc. | 3.32B | -1.26% | 724,503 | - |
| 64 | EWTX | Edgewise Therapeutics, Inc. | 3.29B | 2.82% | 1,457,667 | - |
| 65 | LEGN | Legend Biotech Corporation | 3.16B | -0.81% | 935,158 | 1.03B |
| 66 | TLX | Telix Pharmaceuticals Limited | 2.97B | -3.94% | 235,150 | 803.79M |
| 67 | DYN | Dyne Therapeutics, Inc. | 2.95B | -0.11% | 2,175,502 | - |
| 68 | ALMS | Alumis Inc. | 2.93B | -1.24% | 1,107,154 | 24.05M |
| 69 | VERA | Vera Therapeutics, Inc. | 2.84B | -2.41% | 952,323 | - |
| 70 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.82B | -1.07% | 898,243 | 588.99M |
| 71 | TNGX | Tango Therapeutics, Inc. | 2.78B | 2.74% | 3,002,594 | 62.38M |
| 72 | VRDN | Viridian Therapeutics, Inc. | 2.78B | -1.56% | 1,422,930 | 70.85M |
| 73 | ARQT | Arcutis Biotherapeutics, Inc. | 2.71B | -2.06% | 1,199,834 | 376.07M |
| 74 | ADMA | ADMA Biologics, Inc. | 2.70B | -16.63% | 22,854,847 | 510.17M |
| 75 | TARS | Tarsus Pharmaceuticals, Inc. | 2.69B | -1.53% | 356,628 | 451.36M |
| 76 | IDYA | IDEAYA Biosciences, Inc. | 2.68B | -3.51% | 1,041,086 | 218.71M |
| 77 | RCUS | Arcus Biosciences, Inc. | 2.54B | -5.42% | 1,454,704 | 247.00M |
| 78 | TVTX | Travere Therapeutics, Inc. | 2.47B | -3.46% | 833,732 | 490.73M |
| 79 | BEAM | Beam Therapeutics Inc. | 2.44B | -4.85% | 1,588,483 | 139.74M |
| 80 | MANE | Veradermics, Incorporated | 2.37B | 2.54% | 538,671 | - |
| 81 | MAZE | Maze Therapeutics, Inc. | 2.36B | - | 559,206 | 2.50M |
| 82 | IMNM | Immunome, Inc. | 2.29B | -2.60% | 1,303,961 | 6.94M |
| 83 | IRON | Disc Medicine, Inc. | 2.27B | 0.85% | 565,520 | - |
| 84 | DAWN | Day One Biopharmaceuticals, Inc. | 2.21B | 0.09% | 2,911,916 | 158.18M |
| 85 | APLS | Apellis Pharmaceuticals, Inc. | 2.20B | -1.94% | 3,167,792 | 1.00B |
| 86 | WVE | Wave Life Sciences Ltd. | 2.19B | 0.09% | 2,770,349 | 42.73M |
| 87 | ADPT | Adaptive Biotechnologies Corporation | 2.14B | 1.79% | 1,762,566 | 276.98M |
| 88 | SNDX | Syndax Pharmaceuticals, Inc. | 2.12B | -0.29% | 1,217,006 | 172.35M |
| 89 | NKTR | Nektar Therapeutics | 2.09B | -1.86% | 687,130 | 55.23M |
| 90 | CLDX | Celldex Therapeutics, Inc. | 2.08B | -1.92% | 936,272 | 1.55M |
| 91 | AAPG | Ascentage Pharma Group International | 2.07B | 16.80% | 1,130 | 54.52M |
| 92 | ORKA | Oruka Therapeutics, Inc. | 1.98B | -3.99% | 488,747 | - |
| 93 | GLPG | Galapagos NV | 1.96B | -6.58% | 617,612 | 1.31B |
| 94 | TYRA | Tyra Biosciences, Inc. | 1.96B | -0.56% | 696,124 | - |
| 95 | ZLAB | Zai Lab Limited | 1.93B | -0.80% | 622,475 | 460.16M |
| 96 | STOK | Stoke Therapeutics, Inc. | 1.90B | -3.65% | 688,093 | 184.42M |
| 97 | AUPH | Aurinia Pharmaceuticals Inc. | 1.89B | -2.40% | 1,605,252 | 283.06M |
| 98 | MLYS | Mineralys Therapeutics, Inc. | 1.89B | -3.26% | 881,643 | - |
| 99 | ELVN | Enliven Therapeutics, Inc. | 1.86B | 1.10% | 1,209,098 | - |
| 100 | SRPT | Sarepta Therapeutics, Inc. | 1.85B | -0.56% | 2,201,711 | 2.20B |
| 101 | MESO | Mesoblast Limited | 1.85B | 2.14% | 239,659 | 65.38M |
| 102 | ANAB | AnaptysBio, Inc. | 1.81B | 0.48% | 224,145 | 234.60M |
| 103 | RARE | Ultragenyx Pharmaceutical Inc. | 1.79B | -8.73% | 3,782,625 | 673.00M |
| 104 | DFTX | Definium Therapeutics, Inc. | 1.77B | -1.71% | 1,330,064 | - |
| 105 | OCUL | Ocular Therapeutix, Inc. | 1.76B | - | 3,646,313 | 51.95M |
| 106 | ZYME | Zymeworks Inc. | 1.74B | -1.75% | 487,447 | 105.97M |
| 107 | RLAY | Relay Therapeutics, Inc. | 1.69B | -3.87% | 2,058,874 | 15.36M |
| 108 | VCEL | Vericel Corporation | 1.68B | 1.94% | 567,916 | 276.26M |
| 109 | RXRX | Recursion Pharmaceuticals, Inc. | 1.67B | -1.86% | 13,165,646 | 74.68M |
| 110 | AGIO | Agios Pharmaceuticals, Inc. | 1.66B | 0.85% | 786,621 | 54.03M |
| 111 | CAPR | Capricor Therapeutics, Inc. | 1.66B | -4.09% | 1,097,805 | 11.13M |
| 112 | INVA | Innoviva, Inc. | 1.62B | 0.05% | 728,036 | 411.33M |
| 113 | SLNO | Soleno Therapeutics, Inc. | 1.62B | -1.20% | 2,197,482 | 190.41M |
| 114 | HRMY | Harmony Biosciences Holdings, Inc. | 1.57B | -1.81% | 1,129,720 | 868.45M |
| 115 | SION | Sionna Therapeutics, Inc. | 1.56B | -5.01% | 259,578 | - |
| 116 | GENB | Generate Biomedicines, Inc. | 1.53B | -3.91% | 428,560 | 31.89M |
| 117 | IMCR | Immunocore Holdings plc | 1.52B | -1.33% | 705,474 | 400.02M |
| 118 | NTLA | Intellia Therapeutics, Inc. | 1.51B | -2.29% | 3,533,167 | 67.67M |
| 119 | NVAX | Novavax, Inc. | 1.51B | -4.73% | 3,175,302 | 1.12B |
| 120 | IOVA | Iovance Biotherapeutics, Inc. | 1.49B | -0.28% | 11,851,126 | 263.50M |
| 121 | NUVB | Nuvation Bio Inc. | 1.49B | -1.61% | 2,877,573 | 62.90M |
| 122 | NRIX | Nurix Therapeutics, Inc. | 1.49B | -1.70% | 1,061,787 | 83.98M |
| 123 | OCS | Oculis Holding AG | 1.45B | -0.33% | 214,236 | 1.51M |
| 124 | DMRA | Damora Therapeutics, Inc. | 1.44B | 3.77% | 357,034 | - |
| 125 | NBTX | Nanobiotix S.A. | 1.43B | -3.47% | 67,239 | 11.93M |
| 126 | PHVS | Pharvaris N.V. | 1.39B | -1.40% | 92,290 | - |
| 127 | PVLA | Palvella Therapeutics, Inc. | 1.38B | -0.69% | 275,035 | - |
| 128 | TRVI | Trevi Therapeutics, Inc. | 1.37B | -1.12% | 1,323,876 | - |
| 129 | RAPP | Rapport Therapeutics, Inc. | 1.35B | 1.11% | 197,620 | - |
| 130 | MBX | MBX Biosciences, Inc. | 1.32B | -1.14% | 378,780 | - |
| 131 | ARDX | Ardelyx, Inc. | 1.31B | 0.75% | 4,625,242 | 407.32M |
| 132 | BHVN | Biohaven Ltd. | 1.26B | -4.00% | 2,409,753 | - |
| 133 | IMTX | Immatics N.V. | 1.23B | -3.26% | 981,285 | 56.67M |
| 134 | ATAI | AtaiBeckley Inc. | 1.23B | -0.29% | 5,127,206 | 4.09M |
| 135 | OLMA | Olema Pharmaceuticals, Inc. | 1.21B | -0.29% | 1,484,417 | - |
| 136 | ZBIO | Zenas BioPharma, Inc. | 1.21B | 2.08% | 508,736 | 10.00M |
| 137 | MLTX | MoonLake Immunotherapeutics | 1.20B | -0.95% | 552,510 | - |
| 138 | VIR | Vir Biotechnology, Inc. | 1.20B | -3.05% | 1,889,175 | 68.56M |
| 139 | TSHA | Taysha Gene Therapies, Inc. | 1.19B | -9.03% | 7,366,842 | 9.77M |
| 140 | GLUE | Monte Rosa Therapeutics, Inc. | 1.18B | -2.06% | 1,795,902 | 123.67M |
| 141 | KOD | Kodiak Sciences Inc. | 1.16B | -1.75% | 501,609 | - |
| 142 | ORIC | ORIC Pharmaceuticals, Inc. | 1.11B | -0.27% | 990,727 | - |
| 143 | PGEN | Precigen, Inc. | 1.11B | -3.40% | 5,344,522 | 6.31M |
| 144 | CRVS | Corvus Pharmaceuticals, Inc. | 1.10B | -4.36% | 1,214,376 | - |
| 145 | PHAR | Pharming Group N.V. | 1.09B | -0.25% | 73,156 | 376.13M |
| 146 | TVGN | Tevogen Bio Holdings Inc. | 1.06B | -5.95% | 23,305 | - |
| 147 | SEPN | Septerna, Inc. | 1.05B | -1.43% | 164,457 | 45.95M |
| 148 | EYPT | EyePoint, Inc. | 1.05B | -1.87% | 820,692 | 31.37M |
| 149 | SVRA | Savara Inc. | 1.03B | -0.79% | 2,042,116 | - |
| 150 | ABCL | AbCellera Biologics Inc. | 1.00B | -1.78% | 2,055,343 | 75.13M |
| 151 | BCAX | Bicara Therapeutics Inc. | 994.84M | -1.25% | 448,878 | - |
| 152 | AKTS | Aktis Oncology, Inc. | 978.49M | 2.48% | 540,744 | 5.56M |
| 153 | AVBP | ArriVent BioPharma, Inc. | 970.23M | -1.04% | 384,526 | - |
| 154 | GERN | Geron Corporation | 967.22M | -1.95% | 17,645,231 | 183.88M |
| 155 | CMPX | Compass Therapeutics, Inc. | 959.87M | 5.75% | 1,850,605 | 850.00K |
| 156 | QURE | uniQure N.V. | 949.20M | -4.65% | 1,867,076 | 16.10M |
| 157 | INBX | Inhibrx Biosciences, Inc. | 922.00M | -2.34% | 358,061 | 1.30M |
| 158 | XERS | Xeris Biopharma Holdings, Inc. | 912.16M | -5.70% | 2,059,423 | 291.85M |
| 159 | SLS | SELLAS Life Sciences Group, Inc. | 897.01M | -8.85% | 8,462,176 | - |
| 160 | FTRE | Fortrea Holdings Inc. | 895.73M | -1.74% | 698,210 | 2.72B |
| 161 | XNCR | Xencor, Inc. | 872.00M | -1.33% | 1,275,249 | 125.58M |
| 162 | URGN | UroGen Pharma Ltd. | 859.73M | 2.08% | 750,121 | 109.79M |
| 163 | ABUS | Arbutus Biopharma Corporation | 842.51M | -2.49% | 1,556,409 | 14.08M |
| 164 | IVA | Inventiva S.A. | 837.69M | -0.99% | 69,653 | 19.93M |
| 165 | KALV | KalVista Pharmaceuticals, Inc. | 831.99M | -0.84% | 698,267 | 1.43M |
| 166 | GHRS | GH Research PLC | 830.57M | 1.36% | 104,182 | - |
| 167 | CGEM | Cullinan Therapeutics, Inc. | 825.58M | 6.23% | 1,331,597 | - |
| 168 | JANX | Janux Therapeutics, Inc. | 824.88M | -2.45% | 1,219,875 | 10.00M |
| 169 | PHAT | Phathom Pharmaceuticals, Inc. | 792.72M | -4.82% | 1,197,437 | 175.11M |
| 170 | SGP | SpyGlass Pharma, Inc. | 790.96M | -9.91% | 145,599 | - |
| 171 | SANA | Sana Biotechnology, Inc. | 779.25M | -6.41% | 4,527,631 | - |
| 172 | ANL | Adlai Nortye Ltd. | 773.80M | 0.72% | 81,364 | -1.35M |
| 173 | TBPH | Theravance Biopharma, Inc. | 767.24M | 1.02% | 626,380 | 107.46M |
| 174 | EVMN | Evommune, Inc. | 757.11M | -10.36% | 292,996 | 13.00M |
| 175 | SPRY | ARS Pharmaceuticals, Inc. | 748.70M | -1.69% | 2,498,059 | 84.28M |
| 176 | MPLT | MapLight Therapeutics, Inc. | 741.03M | -0.59% | 287,268 | - |
| 177 | LXRX | Lexicon Pharmaceuticals, Inc. | 728.73M | 4.88% | 2,701,283 | 49.80M |
| 178 | OMER | Omeros Corporation | 721.77M | -4.50% | 956,715 | - |
| 179 | CTMX | CytomX Therapeutics, Inc. | 721.59M | -4.93% | 5,568,272 | 76.20M |
| 180 | KURA | Kura Oncology, Inc. | 712.82M | -3.00% | 983,068 | 67.48M |
| 181 | MNKD | MannKind Corporation | 705.55M | -6.15% | 14,761,421 | 348.97M |
| 182 | DRUG | Bright Minds Biosciences Inc. | 703.37M | -0.39% | 68,710 | - |
| 183 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 697.89M | -1.02% | 125,702 | - |
| 184 | GYRE | Gyre Therapeutics, Inc. | 672.93M | -1.42% | 117,356 | 116.59M |
| 185 | ARVN | Arvinas, Inc. | 658.16M | -0.29% | 764,924 | 262.60M |
| 186 | SLDB | Solid Biosciences Inc. | 657.25M | -6.44% | 760,163 | - |
| 187 | JBIO | Jade Biosciences, Inc. | 653.93M | -4.54% | 278,921 | - |
| 188 | ANRO | Alto Neuroscience, Inc. | 644.98M | 0.85% | 167,350 | - |
| 189 | RLMD | Relmada Therapeutics, Inc. | 639.83M | 4.10% | 1,513,858 | - |
| 190 | DSGN | Design Therapeutics, Inc. | 635.84M | 1.38% | 187,752 | - |
| 191 | PRME | Prime Medicine, Inc. | 635.54M | -1.68% | 2,192,587 | 4.63M |
| 192 | OCGN | Ocugen, Inc. | 629.56M | -8.57% | 17,384,461 | 4.41M |
| 193 | DRTS | Alpha Tau Medical Ltd. | 616.95M | -2.64% | 139,834 | - |
| 194 | MDXG | MiMedx Group, Inc. | 613.58M | -2.59% | 730,768 | 418.63M |
| 195 | ANNX | Annexon, Inc. | 598.16M | -6.89% | 2,714,754 | - |
| 196 | EIKN | Eikon Therapeutics, Inc. | 597.07M | -5.55% | 409,470 | - |
| 197 | MGTX | MeiraGTx Holdings plc | 596.44M | -3.14% | 548,691 | 27.42M |
| 198 | LBRX | LB Pharmaceuticals Inc | 591.24M | -1.27% | 122,609 | - |
| 199 | REPL | Replimune Group, Inc. | 575.53M | -0.14% | 1,661,803 | - |
| 200 | AGMB | AgomAb Therapeutics NV | 567.54M | -4.94% | 439,055 | - |
| 201 | TECX | Tectonic Therapeutic, Inc. | 564.61M | 2.14% | 123,662 | - |
| 202 | VALN | Valneva SE | 556.66M | -1.08% | 605,998 | 205.07M |
| 203 | YDES | YD Bio Limited | 543.57M | 19.11% | 138,671 | 510.36K |
| 204 | ALLO | Allogene Therapeutics, Inc. | 538.75M | -9.43% | 4,422,263 | 22.00K |
| 205 | ZVRA | Zevra Therapeutics, Inc. | 537.21M | -2.87% | 739,348 | 106.47M |
| 206 | DBVT | DBV Technologies S.A. | 535.13M | -2.77% | 210,043 | 5.50M |
| 207 | CRMD | CorMedix Inc. | 510.67M | 0.62% | 1,273,280 | 311.71M |
| 208 | ZURA | Zura Bio Limited | 510.46M | -3.41% | 547,418 | - |
| 209 | ADCT | ADC Therapeutics SA | 500.55M | -2.72% | 406,143 | 81.36M |
| 210 | NAUT | Nautilus Biotechnology, Inc. | 498.91M | 9.12% | 1,164,179 | - |
| 211 | RIGL | Rigel Pharmaceuticals, Inc. | 482.70M | -1.40% | 292,787 | 294.28M |
| 212 | LRMR | Larimar Therapeutics, Inc. | 474.75M | -2.35% | 1,932,539 | - |
| 213 | PRTA | Prothena Corporation plc | 469.96M | -1.02% | 534,726 | 9.68M |
| 214 | FDMT | 4D Molecular Therapeutics, Inc. | 468.65M | -0.54% | 769,942 | 85.21M |
| 215 | RCKT | Rocket Pharmaceuticals, Inc. | 463.59M | -1.61% | 3,629,252 | - |
| 216 | ENGN | enGene Holdings Inc. | 462.23M | -5.61% | 145,689 | - |
| 217 | ABSI | Absci Corporation | 460.59M | 2.73% | 4,649,675 | 2.80M |
| 218 | CTNM | Contineum Therapeutics, Inc. | 460.35M | -0.72% | 681,428 | - |
| 219 | LYEL | Lyell Immunopharma, Inc. | 459.15M | 0.61% | 48,512 | 36.00K |
| 220 | UPB | Upstream Bio, Inc. | 456.63M | - | 747,578 | 2.80M |
| 221 | MRVI | Maravai LifeSciences Holdings, Inc. | 450.86M | 0.33% | 1,547,001 | 185.74M |
| 222 | ASMB | Assembly Biosciences, Inc. | 447.80M | -1.22% | 70,504 | 72.30M |
| 223 | FULC | Fulcrum Therapeutics, Inc. | 446.22M | -2.76% | 1,259,618 | 80.00M |
| 224 | TRDA | Entrada Therapeutics, Inc. | 439.12M | -0.17% | 174,542 | 25.42M |
| 225 | STTK | Shattuck Labs, Inc. | 437.97M | - | 341,569 | 1.00M |
| 226 | VSTM | Verastem, Inc. | 433.03M | -8.53% | 4,272,095 | 30.91M |
| 227 | AVIR | Atea Pharmaceuticals, Inc. | 424.65M | -4.31% | 677,828 | - |
| 228 | EPRX | Eupraxia Pharmaceuticals Inc. | 423.55M | -6.00% | 189,849 | - |
| 229 | DNA | Ginkgo Bioworks Holdings, Inc. | 422.49M | 2.58% | 1,191,101 | 170.16M |
| 230 | ALT | Altimmune, Inc. | 421.43M | -5.81% | 3,345,217 | 41.00K |
| 231 | NMRA | Neumora Therapeutics, Inc. | 412.71M | - | 498,703 | - |
| 232 | IVVD | Invivyd, Inc. | 404.11M | -4.03% | 1,224,538 | 53.43M |
| 233 | VNDA | Vanda Pharmaceuticals Inc. | 403.12M | -2.57% | 1,174,495 | 216.11M |
| 234 | RGNX | REGENXBIO Inc. | 403.10M | -6.35% | 711,898 | 170.44M |
| 235 | IPSC | Century Therapeutics, Inc. | 402.58M | -5.49% | 1,761,111 | 109.16M |
| 236 | LXEO | Lexeo Therapeutics, Inc. | 401.43M | -0.72% | 753,349 | - |
| 237 | AURA | Aura Biosciences, Inc. | 400.71M | -3.37% | 201,087 | - |
| 238 | ACRS | Aclaris Therapeutics, Inc. | 397.96M | -7.82% | 3,905,953 | 7.83M |
| 239 | STRO | Sutro Biopharma, Inc. | 390.49M | 10.50% | 286,796 | 102.48M |
| 240 | AVXL | Anavex Life Sciences Corp. | 388.29M | -5.63% | 1,040,748 | - |
| 241 | PRTC | PureTech Health plc | 378.04M | -0.79% | 1,105 | 6.39M |
| 242 | MNPR | Monopar Therapeutics Inc. | 369.21M | -1.80% | 126,846 | - |
| 243 | LCTX | Lineage Cell Therapeutics, Inc. | 368.65M | 0.68% | 1,019,123 | 14.56M |
| 244 | BNTC | Benitec Biopharma Inc. | 367.59M | -4.38% | 123,572 | - |
| 245 | NAGE | Niagen Bioscience, Inc. | 363.57M | -3.61% | 785,934 | 129.42M |
| 246 | DMAC | DiaMedica Therapeutics Inc. | 358.81M | -5.49% | 209,956 | - |
| 247 | GLSI | Greenwich LifeSciences, Inc. | 355.78M | 1.78% | 91,813 | - |
| 248 | CADL | Candel Therapeutics, Inc. | 352.32M | -3.61% | 965,430 | - |
| 249 | AUTL | Autolus Therapeutics plc | 351.31M | -5.71% | 2,384,623 | 51.13M |
| 250 | ENTA | Enanta Pharmaceuticals, Inc. | 350.55M | -4.51% | 114,432 | 66.98M |
| 251 | XOMA | XOMA Royalty Corporation | 347.88M | -1.73% | 88,292 | 52.15M |
| 252 | XFOR | X4 Pharmaceuticals, Inc. | 347.31M | -6.14% | 284,849 | 35.11M |
| 253 | IMRX | Immuneering Corporation | 338.13M | 2.15% | 582,752 | - |
| 254 | KYTX | Kyverna Therapeutics, Inc. | 334.60M | -3.17% | 598,654 | - |
| 255 | PALI | Palisade Bio, Inc. | 331.77M | 4.71% | 3,045,195 | - |
| 256 | PEPG | PepGen Inc. | 326.22M | -1.26% | 357,121 | - |
| 257 | NGNE | Neurogene Inc. | 323.74M | 7.95% | 295,570 | 925.00K |
| 258 | FBRX | Forte Biosciences, Inc. | 322.19M | 0.43% | 154,387 | - |
| 259 | IRD | Opus Genetics, Inc. | 320.88M | -1.74% | 472,999 | 14.20M |
| 260 | OVID | Ovid Therapeutics Inc. | 319.14M | -5.10% | 2,520,029 | 7.25M |
| 261 | CLYM | Climb Bio, Inc. | 319.09M | 2.14% | 516,401 | - |
| 262 | PBYI | Puma Biotechnology, Inc. | 318.49M | 0.16% | 245,523 | 228.37M |
| 263 | BCYC | Bicycle Therapeutics plc | 313.68M | 3.69% | 1,065,650 | 72.59M |
| 264 | AVTX | Avalo Therapeutics, Inc. | 306.50M | -0.37% | 1,018,833 | 59.00K |
| 265 | PLYX | Polaryx Therapeutics, Inc. | 304.89M | 16.67% | 836,753 | - |
| 266 | ARMP | Armata Pharmaceuticals, Inc. | 298.27M | 1.48% | 18,975 | 5.05M |
| 267 | CABA | Cabaletta Bio, Inc. | 297.23M | -5.32% | 1,687,343 | - |
| 268 | CNTX | Context Therapeutics Inc. | 292.18M | 5.30% | 680,157 | - |
| 269 | ACIU | AC Immune SA | 291.07M | -0.69% | 109,394 | 4.51M |
| 270 | NBP | NovaBridge Biosciences | 290.53M | -4.18% | 1,147,924 | - |
| 271 | IMMX | Immix Biopharma, Inc. | 287.76M | -2.72% | 599,455 | - |
| 272 | CBIO | Crescent Biopharma, Inc. | 287.69M | -5.43% | 215,107 | 10.84M |
| 273 | SRZN | Surrozen, Inc. | 287.17M | -0.95% | 174,776 | 3.48M |
| 274 | LENZ | LENZ Therapeutics, Inc. | 283.13M | -17.91% | 3,912,501 | 19.09M |
| 275 | FHTX | Foghorn Therapeutics Inc. | 281.76M | -5.70% | 162,483 | 30.91M |
| 276 | OBIO | Orchestra BioMed Holdings, Inc. | 272.71M | -2.10% | 262,163 | 33.48M |
| 277 | TARA | Protara Therapeutics, Inc. | 270.96M | -2.91% | 2,088,811 | - |
| 278 | ALXO | ALX Oncology Holdings Inc. | 268.48M | -7.27% | 1,162,627 | - |
| 279 | NERV | Minerva Neurosciences, Inc. | 261.38M | -7.79% | 735,296 | - |
| 280 | RZLT | Rezolute, Inc. | 257.43M | 12.08% | 4,891,244 | - |
| 281 | CHRS | Coherus Oncology, Inc. | 256.31M | 4.27% | 3,107,371 | 42.17M |
| 282 | PROK | ProKidney Corp. | 254.08M | -7.73% | 1,111,543 | 893.00K |
| 283 | ABEO | Abeona Therapeutics Inc. | 247.02M | -2.04% | 1,848,511 | 5.82M |
| 284 | SLN | Silence Therapeutics plc | 245.62M | -10.03% | 672,663 | 559.00K |
| 285 | CCCC | C4 Therapeutics, Inc. | 243.95M | -2.34% | 1,632,362 | 35.95M |
| 286 | OABI | OmniAb, Inc. | 241.79M | -5.11% | 271,766 | 18.67M |
| 287 | CLLS | Cellectis S.A. | 240.53M | -5.56% | 41,854 | 79.59M |
| 288 | CAMP | Camp4 Therapeutics Corporation | 235.19M | -3.41% | 100,530 | 3.50M |
| 289 | VYGR | Voyager Therapeutics, Inc. | 233.63M | 1.03% | 586,544 | 40.37M |
| 290 | ALEC | Alector, Inc. | 229.55M | 0.97% | 594,274 | 21.05M |
| 291 | TENX | Tenax Therapeutics, Inc. | 227.52M | -7.29% | 354,901 | - |
| 292 | HELP | Cybin Inc. | 225.66M | -0.66% | 454,421 | - |
| 293 | SLGL | Sol-Gel Technologies Ltd. | 222.92M | 20.86% | 56,119 | 19.39M |
| 294 | EDIT | Editas Medicine, Inc. | 220.21M | -6.25% | 1,186,558 | 40.52M |
| 295 | ELDN | Eledon Pharmaceuticals, Inc. | 219.21M | -6.77% | 1,372,459 | - |
| 296 | KROS | Keros Therapeutics, Inc. | 216.70M | -2.22% | 460,227 | 244.06M |
| 297 | MDWD | MediWound Ltd. | 213.19M | -1.60% | 38,826 | 16.96M |
| 298 | NVCT | Nuvectis Pharma, Inc. | 210.61M | -3.75% | 57,674 | - |
| 299 | TNXP | Tonix Pharmaceuticals Holding Corp. | 205.64M | -4.60% | 426,587 | 13.11M |
| 300 | SABS | SAB Biotherapeutics, Inc. | 197.18M | -1.53% | 627,392 | 114.70K |
| 301 | PRLD | Prelude Therapeutics Incorporated | 196.57M | -1.27% | 200,427 | 12.14M |
| 302 | CGEN | Compugen Ltd. | 195.73M | -0.96% | 137,360 | 72.76M |
| 303 | ELTX | Elicio Therapeutics, Inc. | 194.08M | -3.30% | 82,477 | - |
| 304 | ARCT | Arcturus Therapeutics Holdings Inc. | 189.01M | -3.20% | 361,218 | 82.03M |
| 305 | CBUS | Cibus, Inc. | 187.52M | -2.17% | 262,506 | 3.64M |
| 306 | GALT | Galectin Therapeutics Inc. | 182.46M | -1.05% | 141,780 | - |
| 307 | ZNTL | Zentalis Pharmaceuticals, Inc. | 178.46M | -2.37% | 418,454 | 26.87M |
| 308 | CRBU | Caribou Biosciences, Inc. | 175.88M | -2.15% | 940,615 | 11.16M |
| 309 | CNTB | Connect Biopharma Holdings Limited | 174.98M | 6.10% | 376,253 | 762.00K |
| 310 | MGNX | MacroGenics, Inc. | 173.51M | -6.51% | 663,823 | 149.50M |
| 311 | NTHI | NeOnc Technologies Holdings, Inc. | 170.87M | -4.44% | 17,419 | 59.99K |
| 312 | ADAG | Adagene Inc. | 170.14M | -7.91% | 67,131 | 103.20K |
| 313 | WHWK | Whitehawk Therapeutics, Inc. | 169.44M | -1.64% | 219,122 | 7.15M |
| 314 | FENC | Fennec Pharmaceuticals Inc. | 169.26M | -19.19% | 809,096 | 44.64M |
| 315 | CNTN | Canton Strategic Holdings, Inc. | 167.44M | -2.69% | 353,983 | - |
| 316 | PLX | Protalix BioTherapeutics, Inc. | 166.47M | -2.82% | 693,054 | 52.74M |
| 317 | TNYA | Tenaya Therapeutics, Inc. | 164.35M | 0.79% | 1,778,427 | - |
| 318 | IMUX | Immunic, Inc. | 163.08M | 6.84% | 2,492,635 | - |
| 319 | MOLN | Molecular Partners AG | 162.74M | -3.55% | 1,395 | 856.30K |
| 320 | RNAC | Cartesian Therapeutics, Inc. | 160.91M | -8.03% | 172,901 | 2.80M |
| 321 | DTIL | Precision BioSciences, Inc. | 158.25M | -1.84% | 291,588 | 34.26M |
| 322 | ABOS | Acumen Pharmaceuticals, Inc. | 156.89M | -4.43% | 651,043 | - |
| 323 | PRQR | ProQR Therapeutics N.V. | 156.46M | -4.19% | 258,272 | 19.19M |
| 324 | PMN | ProMIS Neurosciences, Inc. | 156.31M | -1.91% | 16,496 | - |
| 325 | ACHV | Achieve Life Sciences, Inc. | 154.40M | -28.40% | 4,403,071 | - |
| 326 | EVAX | Evaxion A/S | 153.25M | -5.28% | 18,389 | 7.53M |
| 327 | KRRO | Korro Bio, Inc. | 152.59M | -6.12% | 122,245 | 6.39M |
| 328 | CDXS | Codexis, Inc. | 151.75M | 3.73% | 1,379,300 | 70.39M |
| 329 | SGMT | Sagimet Biosciences Inc. | 150.87M | -5.12% | 371,628 | - |
| 330 | HUMA | Humacyte, Inc. | 148.77M | -6.57% | 7,755,668 | 1.57M |
| 331 | MENS | Jyong Biotech Ltd. | 148.47M | 2.56% | 242,686 | - |
| 332 | NKTX | Nkarta, Inc. | 145.61M | -5.96% | 533,043 | - |
| 333 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 145.08M | -2.97% | 120,631 | - |
| 334 | HRTX | Heron Therapeutics, Inc. | 144.14M | -4.39% | 1,505,972 | 154.90M |
| 335 | KLRS | Kalaris Therapeutics, Inc. | 143.30M | -3.85% | 44,270 | - |
| 336 | VTVT | vTv Therapeutics Inc. | 142.62M | -2.87% | 130,687 | 17.00K |
| 337 | MIST | Milestone Pharmaceuticals Inc. | 142.27M | -7.94% | 3,982,831 | 1.55M |
| 338 | UNCY | Unicycive Therapeutics, Inc. | 137.33M | -5.61% | 615,057 | - |
| 339 | AGEN | Agenus Inc. | 136.70M | -3.52% | 379,161 | 114.20M |
| 340 | ORMP | Oramed Pharmaceuticals Inc. | 136.12M | -3.66% | 174,710 | 2.00M |
| 341 | ANTX | AN2 Therapeutics, Inc. | 135.50M | -1.57% | 451,924 | - |
| 342 | SPRO | Spero Therapeutics, Inc. | 133.52M | 0.85% | 394,992 | 40.55M |
| 343 | FATE | Fate Therapeutics, Inc. | 131.38M | -1.74% | 1,198,033 | 6.65M |
| 344 | ARTV | Artiva Biotherapeutics, Inc. | 129.27M | -2.61% | 78,003 | 251.00K |
| 345 | VOR | Vor Biopharma Inc. | 126.49M | -4.26% | 1,254,590 | - |
| 346 | BDTX | Black Diamond Therapeutics, Inc. | 122.60M | -0.47% | 454,419 | 70.00M |
| 347 | ACOG | Alpha Cognition Inc. | 121.54M | -3.62% | 41,899 | 7.43M |
| 348 | IKT | Inhibikase Therapeutics, Inc. | 120.28M | -8.05% | 6,307,092 | 1.00 |
| 349 | EQ | Equillium, Inc. | 118.74M | -3.47% | 647,805 | 4.39M |
| 350 | SGMO | Sangamo Therapeutics, Inc. | 118.28M | 4.93% | 3,844,263 | 32.88M |
| 351 | CRDF | Cardiff Oncology, Inc. | 118.27M | -2.81% | 500,623 | 593.00K |
| 352 | IPHA | Innate Pharma S.A. | 118.09M | -8.03% | 8,322 | 14.84M |
| 353 | ALDX | Aldeyra Therapeutics, Inc. | 112.54M | -16.14% | 7,333,281 | - |
| 354 | INO | Inovio Pharmaceuticals, Inc. | 108.47M | -2.48% | 691,172 | 65.34K |
| 355 | GNLX | Genelux Corporation | 108.43M | -2.42% | 205,121 | 8.00K |
| 356 | QTTB | Q32 Bio Inc. | 106.80M | 7.99% | 277,826 | 53.74M |
| 357 | RANI | Rani Therapeutics Holdings, Inc. | 103.39M | -7.02% | 1,134,234 | 1.20M |
| 358 | HURA | TuHURA Biosciences, Inc. | 100.98M | -0.51% | 532,612 | - |
| 359 | KPTI | Karyopharm Therapeutics Inc. | 99.79M | -18.32% | 17,851,537 | 146.07M |
| 360 | ONCY | Oncolytics Biotech Inc. | 99.37M | -2.51% | 393,005 | - |
| 361 | TTRX | Turn Therapeutics Inc. | 98.35M | -2.34% | 20,137 | - |
| 362 | COYA | Coya Therapeutics, Inc. | 97.35M | -1.66% | 176,924 | 7.95M |
| 363 | CGTX | Cognition Therapeutics, Inc. | 97.10M | -2.65% | 499,033 | - |
| 364 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 96.63M | -7.39% | 715,445 | - |
| 365 | SEER | Seer, Inc. | 95.92M | -0.29% | 107,865 | 16.58M |
| 366 | FBIO | Fortress Biotech, Inc. | 90.63M | -2.01% | 341,210 | 62.30M |
| 367 | SPRB | Spruce Biosciences, Inc. | 88.30M | 9.40% | 33,708 | 697.00K |
| 368 | MAIA | MAIA Biotechnology, Inc. | 87.37M | -3.36% | 262,421 | - |
| 369 | ANIX | Anixa Biosciences, Inc. | 86.84M | -0.77% | 179,215 | - |
| 370 | DWTX | Dogwood Therapeutics, Inc. | 86.51M | -6.83% | 79,509 | - |
| 371 | PYXS | Pyxis Oncology, Inc. | 85.45M | -4.23% | 550,237 | 13.86M |
| 372 | AARD | Aardvark Therapeutics, Inc. | 82.25M | -7.26% | 462,175 | - |
| 373 | VANI | Vivani Medical, Inc. | 81.71M | -5.08% | 149,815 | - |
| 374 | BMEA | Biomea Fusion, Inc. | 81.70M | 0.89% | 1,027,348 | - |
| 375 | GOSS | Gossamer Bio, Inc. | 80.95M | -7.58% | 23,456,455 | 48.47M |
| 376 | CSBR | Champions Oncology, Inc. | 80.68M | -2.52% | 44,300 | 57.95M |
| 377 | MCRB | Seres Therapeutics, Inc. | 79.37M | -4.50% | 37,718 | 789.00K |
| 378 | PLRX | Pliant Therapeutics, Inc. | 79.25M | -0.39% | 352,098 | - |
| 379 | NRXS | NeurAxis, Inc. | 78.87M | -3.56% | 109,087 | 3.57M |
| 380 | CING | Cingulate Inc. | 78.03M | -3.17% | 577,372 | - |
| 381 | KZIA | Kazia Therapeutics Limited | 77.69M | 0.14% | 101,968 | 1.20M |
| 382 | ATYR | aTyr Pharma, Inc. | 77.42M | -4.57% | 767,771 | 190.00K |
| 383 | VRCA | Verrica Pharmaceuticals Inc. | 76.96M | -7.01% | 141,304 | 35.58M |
| 384 | PYPD | PolyPid Ltd. | 74.27M | -1.69% | 32,756 | - |
| 385 | PMVP | PMV Pharmaceuticals, Inc. | 74.13M | -4.14% | 329,974 | - |
| 386 | PTHS | Pelthos Therapeutics Inc. | 73.82M | - | 2,596 | 16.80M |
| 387 | IFRX | InflaRx N.V. | 73.74M | 5.38% | 307,523 | 34.44K |
| 388 | IBIO | iBio, Inc. | 71.85M | -5.88% | 901,836 | 300.00K |
| 389 | XBIT | XBiotech Inc. | 71.80M | -1.46% | 21,669 | - |
| 390 | MNOV | MediciNova, Inc. | 71.37M | 0.34% | 29,055 | 409.66K |
| 391 | NRXP | NRx Pharmaceuticals, Inc. | 70.43M | 20.34% | 1,574,909 | 1.23M |
| 392 | GRCE | Grace Therapeutics, Inc. | 68.70M | 0.23% | 323,184 | - |
| 393 | GUTS | Fractyl Health, Inc. | 68.28M | -3.48% | 8,404,111 | 3.00K |
| 394 | ANVS | Annovis Bio, Inc. | 67.20M | -5.20% | 318,498 | - |
| 395 | GANX | Gain Therapeutics, Inc. | 67.14M | -1.59% | 563,513 | - |
| 396 | IBO | Impact BioMedical Inc. | 66.85M | -4.14% | 239,374 | 32.00K |
| 397 | BYSI | BeyondSpring Inc. | 66.15M | -0.61% | 14,471 | 1.88M |
| 398 | COEP | Coeptis Therapeutics Holdings, Inc. | 64.72M | -5.97% | 68,114 | 1.36M |
| 399 | ACET | Adicet Bio, Inc. | 64.20M | 0.45% | 75,358 | - |
| 400 | ACRV | Acrivon Therapeutics, Inc. | 61.22M | -1.25% | 466,234 | - |
| 401 | EXOZ | eXoZymes, Inc. | 60.81M | -1.76% | 2,681 | -700.00 |
| 402 | ATHE | Alterity Therapeutics Limited | 60.36M | 0.91% | 6,036 | 4.43M |
| 403 | HYFT | MindWalk Holdings Corp. | 59.60M | - | 147,626 | 20.70M |
| 404 | TCRX | TScan Therapeutics, Inc. | 58.61M | -0.96% | 398,161 | 10.33M |
| 405 | EDSA | Edesa Biotech, Inc. | 58.60M | -9.77% | 507,799 | - |
| 406 | TIL | Instil Bio, Inc. | 58.05M | 0.59% | 13,851 | - |
| 407 | ICCC | ImmuCell Corporation | 57.80M | -0.31% | 8,889 | 27.64M |
| 408 | IMA | ImageneBio, Inc. | 57.64M | -3.91% | 12,372 | 800.00K |
| 409 | OKUR | OnKure Therapeutics, Inc. | 54.42M | - | 156,778 | - |
| 410 | LPCN | Lipocine Inc. | 53.73M | 0.68% | 72,137 | 1.98M |
| 411 | MREO | Mereo BioPharma Group plc | 53.63M | -1.93% | 1,529,399 | 500.00K |
| 412 | IMMP | Immutep Limited | 52.99M | -6.28% | 1,657,757 | 5.28M |
| 413 | MGX | Metagenomi Therapeutics, Inc. | 51.54M | -4.20% | 242,955 | 25.21M |
| 414 | ACTU | Actuate Therapeutics, Inc. | 51.37M | -9.43% | 90,106 | - |
| 415 | RADX | Radiopharm Theranostics Limited | 48.91M | -10.78% | 7,101,434 | 10.86M |
| 416 | OSTX | OS Therapies Incorporated | 48.60M | -9.21% | 746,654 | - |
| 417 | XLO | Xilio Therapeutics, Inc. | 48.40M | - | 73,092 | 43.77M |
| 418 | ATOS | Atossa Therapeutics, Inc. | 47.45M | -1.78% | 41,232 | - |
| 419 | ENTX | Entera Bio Ltd. | 47.23M | -5.50% | 98,031 | 124.00K |
| 420 | KZR | Kezar Life Sciences, Inc. | 46.94M | -0.31% | 19,733 | - |
| 421 | DCOY | Decoy Therapeutics Inc. | 46.38M | -2.68% | 5,173 | - |
| 422 | GOVX | GeoVax Labs, Inc. | 46.29M | 2.67% | 29,108 | 3.35M |
| 423 | RLYB | Rallybio Corporation | 45.76M | -5.05% | 100,279 | 858.00K |
| 424 | LSTA | Lisata Therapeutics, Inc. | 45.34M | - | 33,344 | 170.00K |
| 425 | NTRB | Nutriband Inc. | 45.13M | -2.34% | 9,024 | 2.28M |
| 426 | TELO | Telomir Pharmaceuticals, Inc. | 44.01M | - | 61,007 | - |
| 427 | LITS | Lite Strategy, Inc. | 43.63M | 1.69% | 347,598 | - |
| 428 | ALGS | Aligos Therapeutics, Inc. | 41.71M | -1.89% | 45,361 | 2.19M |
| 429 | PSTV | Plus Therapeutics, Inc. | 41.16M | -1.80% | 2,116,760 | 5.21M |
| 430 | ATRA | Atara Biotherapeutics, Inc. | 40.81M | 2.99% | 99,335 | 120.77M |
| 431 | INKT | MiNK Therapeutics, Inc. | 40.18M | -2.95% | 40,849 | - |
| 432 | NBY | NovaBay Pharmaceuticals, Inc. | 39.94M | 8.70% | 1,217,878 | 10.30M |
| 433 | RNXT | RenovoRx, Inc. | 39.58M | -2.70% | 629,024 | 928.00K |
| 434 | SNSE | Sensei Biotherapeutics, Inc. | 37.81M | -8.57% | 71,434 | - |
| 435 | APLM | Apollomics, Inc. | 37.65M | -1.48% | 2,412 | 6.93M |
| 436 | HOWL | Werewolf Therapeutics, Inc. | 37.38M | -6.50% | 225,977 | 1.14M |
| 437 | VERU | Veru Inc. | 36.92M | - | 23,104 | 16.89M |
| 438 | ESLA | Estrella Immunopharma, Inc. | 36.82M | -4.42% | 72,229 | - |
| 439 | CELU | Celularity Inc. | 36.62M | 4.96% | 48,124 | 40.58M |
| 440 | PTN | Palatin Technologies, Inc. | 36.29M | -3.59% | 4,489 | 8.96M |
| 441 | CRVO | CervoMed Inc. | 36.29M | -2.49% | 56,641 | 4.01M |
| 442 | LONA | LeonaBio, Inc. | 35.57M | -3.74% | 33,124 | - |
| 443 | NXTC | NextCure, Inc. | 35.39M | -4.51% | 62,828 | - |
| 444 | ATNM | Actinium Pharmaceuticals, Inc. | 33.38M | -6.14% | 197,238 | 90.00K |
| 445 | JSPR | Jasper Therapeutics, Inc. | 32.18M | -3.36% | 222,817 | - |
| 446 | RNTX | Rein Therapeutics Inc. | 32.07M | 2.52% | 189,233 | - |
| 447 | TVRD | Tvardi Therapeutics, Inc. | 31.52M | -6.67% | 30,833 | - |
| 448 | INMB | INmune Bio Inc. | 31.37M | -4.84% | 272,433 | 50.00K |
| 449 | TLSA | Tiziana Life Sciences Ltd | 31.37M | -2.22% | 238,470 | - |
| 450 | BCTX | BriaCell Therapeutics Corp. | 30.95M | -3.53% | 103,602 | - |
| 451 | PLUR | Pluri Inc. | 30.65M | -0.33% | 7,230 | 1.34M |
| 452 | DYAI | Dyadic International, Inc. | 30.56M | -1.80% | 38,883 | 3.34M |
| 453 | CVM | CEL-SCI Corporation | 28.93M | -1.72% | 30,893 | - |
| 454 | ABVC | ABVC BioPharma, Inc. | 28.75M | -8.13% | 40,666 | 797.92K |
| 455 | CRIS | Curis, Inc. | 28.58M | -3.35% | 425,796 | 9.44M |
| 456 | XCUR | Exicure, Inc. | 28.49M | 1.82% | 27,007 | 500.00K |
| 457 | HYPD | Hyperion DeFi, Inc. | 27.61M | - | 135,967 | 345.32K |
| 458 | KYNB | Kyntra Bio, Inc. | 27.32M | -4.39% | 50,275 | 6.44M |
| 459 | PDSB | PDS Biotechnology Corporation | 26.94M | -3.58% | 589,160 | - |
| 460 | ENLV | Enlivex Ltd. | 26.24M | -0.90% | 298,212 | - |
| 461 | SER | Serina Therapeutics, Inc. | 25.91M | -22.86% | 2,656,580 | 116.00K |
| 462 | BOLD | Boundless Bio, Inc. | 25.54M | -0.87% | 58,915 | - |
| 463 | LTRN | Lantern Pharma Inc. | 24.94M | -0.45% | 29,215 | - |
| 464 | CUE | Cue Biopharma, Inc. | 24.89M | -4.24% | 604,886 | 27.47M |
| 465 | VTGN | Vistagen Therapeutics, Inc. | 24.42M | -0.02% | 178,722 | 789.00K |
| 466 | NRSN | NeuroSense Therapeutics Ltd. | 24.38M | -1.48% | 532,610 | - |
| 467 | NEUP | Neuphoria Therapeutics Inc. | 24.31M | -2.17% | 68,554 | 14.99M |
| 468 | TPST | Tempest Therapeutics, Inc. | 23.59M | -4.89% | 99,151 | - |
| 469 | IGC | IGC Pharma, Inc. | 23.50M | -8.10% | 340,967 | 1.11M |
| 470 | BRNS | Barinthus Biotherapeutics plc | 22.71M | -8.85% | 471,153 | 14.97M |
| 471 | SNTI | Senti Biosciences, Inc. | 22.64M | -4.30% | 75,113 | - |
| 472 | PASG | Passage Bio, Inc. | 21.46M | -4.97% | 31,899 | - |
| 473 | MRKR | Marker Therapeutics, Inc. | 21.01M | -3.82% | 237,730 | 3.55M |
| 474 | SKYE | Skye Bioscience, Inc. | 20.86M | -2.62% | 111,958 | - |
| 475 | LGVN | Longeveron Inc. | 20.79M | -6.28% | 1,437,059 | 1.20M |
| 476 | NNVC | NanoViricides, Inc. | 20.52M | -3.09% | 165,812 | - |
| 477 | VYNE | VYNE Therapeutics Inc. | 19.98M | -1.61% | 198,907 | 570.00K |
| 478 | LEXX | Lexaria Bioscience Corp. | 19.46M | 7.12% | 339,087 | 522.00K |
| 479 | DARE | Daré Bioscience, Inc. | 19.43M | -0.73% | 26,951 | -57.13K |
| 480 | QNTM | Quantum BioPharma Ltd. | 18.16M | 52.58% | 2,911,251 | - |
| 481 | ALLR | Allarity Therapeutics, Inc. | 17.71M | -1.75% | 105,215 | - |
| 482 | KTTA | Pasithea Therapeutics Corp. | 17.68M | -0.55% | 725,617 | - |
| 483 | FBLG | FibroBiologics, Inc. | 17.39M | 2.96% | 805,265 | - |
| 484 | TRAW | Traws Pharma, Inc. | 17.18M | -3.15% | 11,944 | 2.85M |
| 485 | OTLK | Outlook Therapeutics, Inc. | 16.46M | -38.06% | 24,207,723 | 205.70K |
| 486 | CTXR | Citius Pharmaceuticals, Inc. | 15.89M | -5.48% | 460,703 | 3.94M |
| 487 | LIXT | Lixte Biotechnology Holdings, Inc. | 15.40M | 1.50% | 29,371 | - |
| 488 | INAB | IN8bio, Inc. | 15.26M | -6.63% | 91,083 | - |
| 489 | INTS | Intensity Therapeutics, Inc. | 15.00M | -4.82% | 32,888 | - |
| 490 | GTBP | GT Biopharma, Inc. | 14.99M | 1.41% | 1,029,551 | - |
| 491 | AEON | AEON Biopharma, Inc. | 14.63M | -5.36% | 34,756 | - |
| 492 | COCP | Cocrystal Pharma, Inc. | 14.61M | -1.85% | 48,361 | - |
| 493 | PHIO | Phio Pharmaceuticals Corp. | 14.17M | -2.40% | 210,109 | - |
| 494 | GNTA | Genenta Science S.p.A. | 13.79M | 8.19% | 47,254 | - |
| 495 | HOTH | Hoth Therapeutics, Inc. | 13.75M | -5.03% | 567,213 | - |
| 496 | IOBT | IO Biotech, Inc. | 13.74M | -8.61% | 998,436 | - |
| 497 | PLRZ | Polyrizon Ltd. | 13.31M | -5.03% | 45,246 | - |
| 498 | JUNS | Jupiter Neurosciences, Inc. | 13.20M | -3.86% | 83,107 | - |
| 499 | BCDA | BioCardia, Inc. | 13.18M | 0.42% | 42,252 | 3.00K |
| 500 | KAPA | Kairos Pharma, Ltd. | 13.10M | 1.68% | 87,180 | - |
| 501 | QNRX | Quoin Pharmaceuticals, Ltd. | 12.93M | -1.96% | 2,774 | - |
| 502 | CLRB | Cellectar Biosciences, Inc. | 12.76M | -3.53% | 14,203 | - |
| 503 | ACXP | Acurx Pharmaceuticals, Inc. | 12.22M | -5.41% | 1,012,881 | - |
| 504 | MBRX | Moleculin Biotech, Inc. | 12.01M | 7.14% | 158,253 | - |
| 505 | GDTC | CytoMed Therapeutics Limited | 12.00M | 0.97% | 694 | 573.19K |
| 506 | CVKD | Cadrenal Therapeutics, Inc. | 11.89M | -6.83% | 137,609 | - |
| 507 | SNGX | Soligenix, Inc. | 11.80M | -3.31% | 121,390 | 2.34K |
| 508 | OSRH | OSR Holdings, Inc. | 11.66M | -5.18% | 702,880 | -90.52K |
| 509 | CMMB | Chemomab Therapeutics Ltd. | 11.29M | -6.55% | 39,714 | - |
| 510 | NCEL | NewcelX Ltd. | 11.03M | -1.22% | 5,088 | - |
| 511 | BLRX | BioLineRx Ltd. | 10.53M | 4.31% | 33,381 | 1.18M |
| 512 | ONCO | Onconetix, Inc. | 10.28M | -4.69% | 453,619 | 815.37K |
| 513 | BIVI | BioVie Inc. | 9.96M | -0.75% | 26,144 | - |
| 514 | CALC | CalciMedica, Inc. | 9.77M | -4.01% | 158,868 | - |
| 515 | TOVX | Theriva Biologics, Inc. | 9.72M | 0.90% | 22,826,465 | - |
| 516 | CLGN | CollPlant Biotechnologies Ltd. | 9.09M | 17.15% | 40,513 | 2.48M |
| 517 | IMNN | Imunon, Inc. | 9.03M | -1.34% | 33,134 | - |
| 518 | ITRM | Iterum Therapeutics plc | 8.86M | -1.35% | 393,292 | 390.00K |
| 519 | LNAI | Lunai Bioworks Inc. | 8.83M | -11.08% | 1,943,638 | - |
| 520 | BCAB | BioAtla, Inc. | 8.71M | -12.88% | 2,425,891 | 11.00M |
| 521 | PMCB | PharmaCyte Biotech, Inc. | 8.37M | 7.93% | 567,993 | - |
| 522 | BOLT | Bolt Biotherapeutics, Inc. | 8.24M | -2.05% | 14,681 | 7.70M |
| 523 | ICU | SeaStar Medical Holding Corporation | 8.07M | 1.36% | 177,264 | 881.00K |
| 524 | PULM | Pulmatrix, Inc. | 7.85M | -4.87% | 11,944 | 3.00K |
| 525 | RNAZ | TransCode Therapeutics, Inc. | 7.80M | -5.26% | 11,613 | - |
| 526 | PHGE | BiomX Inc. | 7.75M | 4.74% | 66,904 | - |
| 527 | APRE | Aprea Therapeutics, Inc. | 7.71M | -1.26% | 54,774 | 285.76K |
| 528 | EVGN | Evogene Ltd. | 7.69M | -5.62% | 169,683 | 3.85M |
| 529 | KPRX | Kiora Pharmaceuticals, Inc. | 7.58M | 0.98% | 22,640 | 20.00K |
| 530 | ADXN | Addex Therapeutics Ltd | 7.57M | -0.32% | 890 | 198.82K |
| 531 | APM | Aptorum Group Limited | 7.34M | -4.48% | 243,155 | - |
| 532 | SPRC | SciSparc Ltd. | 7.06M | -3.76% | 11,692 | 1.31M |
| 533 | TCRT | Alaunos Therapeutics, Inc. | 7.01M | -1.88% | 19,477 | 6.00K |
| 534 | XBIO | Xenetic Biosciences, Inc. | 6.85M | -4.47% | 9,618 | 2.98M |
| 535 | ALZN | Alzamend Neuro, Inc. | 6.85M | -3.23% | 66,306 | - |
| 536 | GRDX | GridAI Technologies Corp. | 6.82M | -3.79% | 76,824 | - |
| 537 | CELZ | Creative Medical Technology Holdings, Inc. | 6.69M | -2.69% | 10,310 | 6.00K |
| 538 | NCNA | NuCana plc | 6.62M | -4.22% | 26,458 | - |
| 539 | CYCN | Cyclerion Therapeutics, Inc. | 6.44M | 3.14% | 63,570 | 2.86M |
| 540 | IMRN | Immuron Limited | 6.37M | 11.43% | 18,997 | 4.99M |
| 541 | CDIO | Cardio Diagnostics Holdings, Inc. | 6.33M | -4.89% | 239,693 | 14.83K |
| 542 | PCSA | Processa Pharmaceuticals, Inc. | 6.20M | -0.85% | 10,559 | - |
| 543 | ERNA | Ernexa Therapeutics Inc. | 6.17M | -9.87% | 807,047 | 1,000.00 |
| 544 | XTLB | XTL Biopharmaceuticals Ltd. | 5.76M | 12.06% | 44,658 | 968.00K |
| 545 | PBM | Psyence Biomedical Ltd. | 5.57M | - | 5,101 | - |
| 546 | LIMN | Liminatus Pharma, Inc. | 5.48M | -4.49% | 747,641 | - |
| 547 | MBIO | Mustang Bio, Inc. | 5.44M | -0.48% | 65,898 | - |
| 548 | QNCX | Quince Therapeutics, Inc. | 5.18M | -8.37% | 8,541,328 | - |
| 549 | BGMS | Bio Green Med Solution, Inc. | 4.95M | -1.94% | 72,239 | 81.00K |
| 550 | SILO | Silo Pharma, Inc. | 4.94M | 6.70% | 660,544 | 72.10K |
| 551 | MLEC | Moolec Science SA | 4.92M | -8.39% | 12,095 | 7.83M |
| 552 | AKTX | Akari Therapeutics, Plc | 4.91M | -5.17% | 285,619 | - |
| 553 | SLXN | Silexion Therapeutics Corp | 4.46M | 5.51% | 216,757 | - |
| 554 | AZTR | Azitra, Inc. | 4.44M | -7.71% | 7,188,128 | 7.50K |
| 555 | GNPX | Genprex, Inc. | 4.38M | -1.05% | 176,947 | - |
| 556 | ARTL | Artelo Biosciences, Inc. | 4.26M | -24.41% | 550,290 | - |
| 557 | VIVS | VivoSim Labs, Inc. | 4.22M | -2.41% | 980,607 | 142.00K |
| 558 | REVB | Revelation Biosciences, Inc. | 4.17M | -8.20% | 57,081 | - |
| 559 | BDRX | Biodexa Pharmaceuticals Plc | 4.09M | -3.49% | 36,412 | 104.90K |
| 560 | ASBP | Aspire Biopharma Holdings, Inc. | 4.03M | -7.64% | 300,064 | 1.94K |
| 561 | APVO | Aptevo Therapeutics Inc. | 3.95M | -6.01% | 22,104 | - |
| 562 | MTNB | Matinas BioPharma Holdings, Inc. | 3.91M | -4.69% | 14,696 | - |
| 563 | INDP | Indaptus Therapeutics, Inc. | 3.81M | -1.73% | 23,166 | - |
| 564 | PPBT | Purple Biotech Ltd | 3.69M | -0.38% | 6,505 | - |
| 565 | GRI | GRI Bio, Inc. | 3.51M | -6.18% | 27,271 | - |
| 566 | XRTX | XORTX Therapeutics Inc. | 3.25M | -4.94% | 18,029 | - |
| 567 | GLMD | Galmed Pharmaceuticals Ltd. | 3.22M | 1.29% | 20,974 | - |
| 568 | OGEN | Oragenics, Inc. | 2.82M | -4.33% | 63,490 | - |
| 569 | ENVB | Enveric Biosciences, Inc. | 2.71M | -2.50% | 7,770 | - |
| 570 | BRTX | BioRestorative Therapies, Inc. | 2.60M | -10.34% | 2,489,014 | 383.40K |
| 571 | ADIL | Adial Pharmaceuticals, Inc. | 2.41M | -8.15% | 67,056 | - |
| 572 | SCNI | Scinai Immunotherapeutics Ltd. | 2.12M | -0.96% | 4,041 | 1.15M |
| 573 | BBLG | Bone Biologics Corporation | 2.05M | -3.39% | 11,822 | - |
| 574 | CLDI | Calidi Biotherapeutics, Inc. | 2.04M | -3.56% | 927,435 | - |
| 575 | ENSC | Ensysce Biosciences, Inc. | 1.95M | -5.67% | 173,429 | 4.49M |
| 576 | DRMA | Dermata Therapeutics, Inc. | 1.82M | -1.27% | 452,742 | - |
| 577 | KALA | KALA BIO, Inc. | 1.74M | -8.72% | 3,769,241 | - |
| 578 | CNSP | CNS Pharmaceuticals, Inc. | 1.68M | 7.75% | 16,334 | - |
| 579 | PPCB | Propanc Biopharma, Inc. | 1.67M | -5.94% | 3,870,374 | - |
| 580 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 1.50M | -22.40% | 590,597 | 1.36M |
| 581 | JAGX | Jaguar Health, Inc. | 1.48M | -0.50% | 154,434 | 11.79M |
| 582 | HCWB | HCW Biologics Inc. | 1.39M | -17.89% | 1,343,118 | 422.03K |
| 583 | CMND | Clearmind Medicine Inc. | 1.00M | -0.52% | 14,672 | - |
| 584 | OKYO | OKYO Pharma Limited | 921.14K | -3.03% | 93,284 | - |
| 585 | CDT | CDT Equity Inc. | 804.60K | 1.60% | 64,898 | - |
| 586 | VRAX | Virax Biolabs Group Limited | 771.57K | 0.68% | 281,210 | 2.99K |
| 587 | ADTX | Aditxt, Inc. | 539.92K | -10.64% | 149,014 | 5.95K |
| 588 | MTVA | MetaVia Inc. | 273.91K | -10.27% | 324,485 | - |
| 589 | ELAB | PMGC Holdings Inc. | 242.62K | -22.52% | 19,555,072 | 285.95K |
| 590 | CANF | Can-Fite BioPharma Ltd. | 17.81K | -3.40% | 46,892 | 560.00K |